Low PAI-1 activity in relation to the risk for perioperative bleeding complications in transurethral resection of the prostate.

INTRODUCTION: Low levels of plasminogen activator inhibitor type 1 (PAI-1) have been associated with increased risk for perioperative bleeding in some case reports. The aim of this study was to investigate prospectively whether low PAI-1 activity increases the risk for perioperative bleeding in patients undergoing transurethral resection of prostate, an organ with high fibrinolytic activity. PATIENTS AND METHODS: 62 patients with benign prostatic hyperplasia planned for transurethral resection were included. Blood samples for PAI-1 were taken together with other routine preoperative blood samples 1week before surgery but analyzed after the hospitalization. The intraoperative blood loss was determined by measuring the amount of hemoglobin in the irrigating fluid. The postoperative blood loss was estimated from calculations of hemoglobin mass (Hb mass), which is a product of hemoglobin concentration and blood volume. Hb mass was calculated before surgery and on the day of discharge, and was adjusted for intraoperative blood loss and transfused Hb mass. Bleeding complications were defined as re-operation due to bleeding, more than 40ml intraoperative bleeding/g resected prostatic tissue or postoperative blood loss corresponding to more than 100g of hemoglobin. RESULTS: Bleeding complications were observed in 3 of 4 (75%) patients with low PAI-1 levels, defined as <1U/ml, and in 16 of 58 (28%) patients with PAI-1 levels >1U/ml (P=0.082). After adjustment for resection time, resected prostatic mass and systolic blood pressure this became borderline significant (odds ratio 11.8; 95% confidence interval 1.00-139; P=0.05). CONCLUSION: Low PAI-1 activity may contribute to the risk of bleeding after transurethral resection of the prostate.

Transurethral resection of the prostate. A review of 1111 cases.

A review of 1111 transurethral resections of the prostate (TURP) revealed a mortality of 0.5% (6 patients). A stricture frequency of 3% was observed as a complication after the operation. A supplementary resection was done within one year in 9%. Transurethral resection syndrome of the prostate (TURP syndrome) occurred in two patients. Cancer incidence was 18%. Blood transfusions were given to 20% of the patients. The weight of resected prostatic tissue ranged from 4 to 115 g (mean 25 g), and was less than 20 g in 60%. Peroperative bleeding amounting to over 1800 ml occurred in 3.3% (37 patients).

Absorption and elimination of mannitol solution when used as an isotonic irrigating agent in connection with transurethral resection of the prostate.

12 patients were studied in connection with transurethral resection of the prostate using the intermittent technique and isotonic 5% mannitol solution as an irrigating fluid. No diuretics were given postoperatively. The serum creatinine concentrations were normal in 10 patients and slightly elevated in 2. The plasma mannitol levels were followed for four hours postoperatively. The highest concentration observed in the series was 6,275 mg/l (34.9 mmol/l) immediately postoperatively. The maximum level was observed immediately postoperatively in all patients (mean 2,140 mg/l, 11.9 mmol/l). The mean half-life of mannitol in plasma was 163 min (10 patients). The patient with the highest serum creatinine concentration preoperatively (138 mumol/l) showed a marked prolongation of the half-life (692 min). The mean intravenous fluid absorption calculated from the immediate postoperative mannitol concentrations was 0.68 l (range 0.05-1.78 l). A decrease in the serum sodium concentration was observed immediately postoperatively (mean 5.4 mmol/l, range 0-19 mmol/l). There was a correlation between the decreases in the serum sodium concentration and the simultaneous plasma mannitol concentration. There was no significant change in plasma osmolality. Mannitol elimination in urine was followed for 24 hours postoperatively in 7 patients. The mean absorbed volume of irrigating fluid was calculated from the elimination data and was found to be 0.481, which should be compared with the figure obtained from the calculation based on the immediate postoperative plasma mannitol concentration, which gave 0.49 l (mean) in the same 7 patients. This shows that, in spite of the theoretical assumptions made in the calculation of absorbed fluid volume from the plasma mannitol concentration, this method of calculation is valid.(ABSTRACT TRUNCATED AT 250 WORDS)